Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Generalized lymphedema in a sirolimus-treated renal transplant patient
    De Bartolomeis, Carmine
    Collini, Andrea
    Rumberger, Brigitta
    Barni, Roberto
    Ruggieri, Giuliana
    Bernini, Marco
    Carmellini, Mario
    CLINICAL TRANSPLANTATION, 2008, 22 (02) : 254 - 257
  • [2] Steroid minimization for sirolimus-treated renal transplant recipients
    Matas, Arthur J.
    Granger, Darla
    Kaufman, Dixon B.
    Sarwal, Minnie M.
    Ferguson, Ronald M.
    Woodle, E. Steve
    Gill, John S.
    CLINICAL TRANSPLANTATION, 2011, 25 (03) : 457 - 467
  • [3] Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer
    Courtellemont, C.
    Guitard, J.
    Mehrenberger, M.
    Pontier, S.
    Ribes, D.
    Kamar, N.
    Esposito, L.
    Modesto, A.
    Rostaing, L.
    CLINICAL NEPHROLOGY, 2007, 67 (02) : 114 - 118
  • [4] ANAEMIA IN SIROLIMUS-TREATED RENAL TRANSPLANT RECIPIENTS: THE IMPORTANCE OF PRESERVING RENAL FUNCTION
    Russ, G.
    Eris, J.
    Hutchison, B.
    Walker, R.
    Chapman, J.
    Pussell, B.
    Campbell, S.
    NEPHROLOGY, 2006, 11 : A37 - A37
  • [5] Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function
    Friend, Peter
    Russ, Graeme
    Oberbauer, Rainer
    Murgia, Maria G.
    Tufveson, Gunnar
    Chapman, Jeremy
    Blancho, Gilles
    Mota, Alfredo
    Grandaliano, Giuseppe
    Campistol, Josep M.
    Brault, Yves
    Burke, James T.
    TRANSPLANT INTERNATIONAL, 2007, 20 (09) : 754 - 760
  • [6] Risk factors for wound healing complications in sirolimus-treated renal transplant recipients
    Grim, S. A.
    Slover, C. M.
    Sankary, H.
    Oberholzer, J.
    Benedetti, E.
    Clark, N. M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3520 - 3523
  • [7] Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients
    Knight, Richard J.
    Villa, Martin
    Laskey, Robert
    Benavides, Carlos
    Schoenberg, Linda
    Welsh, Maria
    Kerman, Ronald H.
    Podder, Hemangshu
    Van Buren, Charles T.
    Katz, Stephen M.
    Kahan, Barry D.
    CLINICAL TRANSPLANTATION, 2007, 21 (04) : 460 - 465
  • [8] Rabbit antithyrnocyte globulin: A postoperative risk factor for sirolimus-treated renal transplant patients?
    Benavides, C
    Mahmoud, KH
    Knight, R
    Barcenas, C
    Kahan, BD
    Van Buren, CT
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 822 - 826
  • [9] Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination
    Gonwa, TA
    Hricik, DE
    Brinker, K
    Grinyo, JM
    Schena, FP
    TRANSPLANTATION, 2002, 74 (11) : 1560 - 1567
  • [10] Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients
    Ozaki, KS
    Câmara, NOS
    Galante, NZ
    Camargo, LFA
    Pacheco-Silva, A
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (01) : 103 - 106
12345